PepGen Inc. (PEPG)
NASDAQ: PEPG · Real-Time Price · USD
6.76
+0.34 (5.30%)
At close: Mar 4, 2026, 4:00 PM EST
5.54
-1.22 (-18.05%)
Pre-market: Mar 5, 2026, 4:31 AM EST
PepGen Market Cap
PepGen has a market cap or net worth of $464.74 million as of March 5, 2026. Its market cap has increased by 918.40% in one year.
Market Cap
464.74M
Enterprise Value
333.29M
1-Year Change
918.40%
Ranking
Category
Stock Price
$6.76
Market Cap Chart
Since May 6, 2022, PepGen's market cap has increased from $288.65M to $464.74M, an increase of 61.01%. That is a compound annual growth rate of 13.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 464.74M | 3.84% |
| Dec 31, 2025 | 447.55M | 262.28% |
| Dec 31, 2024 | 123.54M | -23.71% |
| Dec 29, 2023 | 161.93M | -48.75% |
| Dec 30, 2022 | 315.96M | 9.46% |
| May 6, 2022 | 288.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Invivyd | 482.20M |
| Solid Biosciences | 478.37M |
| Lineage Cell Therapeutics | 472.54M |
| Assembly Biosciences | 471.19M |
| Anavex Life Sciences | 463.36M |
| REGENXBIO | 462.70M |
| 4D Molecular Therapeutics | 455.50M |
| Immix Biopharma | 451.07M |